Mammography screening for women 40-49 years old not supported by data -- NIH panel.
This article was originally published in The Gray Sheet
Executive Summary
MAMMOGRAPHY SCREENING TECHNIQUES TO REDUCE FALSE POSITIVES, INCREASE SENSITIVITY is one of 17 areas that should get further research, a National Institutes of Health consensus panel said at a Jan. 21-23 meeting in Bethesda, Maryland. The panel declined to make a recommendation on the ongoing debate over whether women 40-49 years old should receive regular mammograms, concluding that questions in areas such as false positive rates and potential overtreatment remained unanswered.
You may also be interested in...
Senate HELP Subcommittee Will Assess Value of Screening Mammograms
The American College of Radiology plans to submit testimony to the Senate HELP/Public Health Subcommittee countering recent claims that mammography does not contribute to breast cancer mortality reduction
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.